Old Tappan, NJ, United States of America

Andrews S Tomcufcik

This inventor holds 1 USPTO granted patent. Top assignee: American Cyanamid Company. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrews S Tomcufcik. Retrieved from https://idiyas.com/inventor/andrews-s-tomcufcik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Andrews S Tomcufcik

Introduction

Andrews S Tomcufcik is a notable inventor hailing from Old Tappan, New Jersey. With a keen focus on pharmaceuticals, he has developed innovative compounds that hold potential in the medical field.

Latest Patents

Andrews holds a significant patent for a compound titled 3-(.alpha.-Substituted-benzyl)-2,3-dihydrothiazolo. This invention discloses novel 3-(.alpha.-substituted-benzyl)-2,3-dihydrothiazolo[3,2-a][1,3]diazacyclan-3-ols, which are identified as useful diuretic agents. His work demonstrates a commitment to addressing health-related challenges through scientific innovation.

Career Highlights

Currently, Andrews is affiliated with the American Cyanamid Company, where he continues to contribute to the advancement of medicinal chemistry. His expertise in pharmaceuticals is further complemented by his single but impactful patent.

Collaborations

Throughout his career, Andrews has worked alongside accomplished professionals like William B Wright, Jr. and Joseph W Marsico, Jr. These collaborations highlight the importance of teamwork in driving innovation within the industry.

Conclusion

Andrews S Tomcufcik's contributions, through his patent and collaborations, underscore the significance of innovation in developing effective medical solutions. His work not only enhances the portfolio of American Cyanamid Company but also reflects the ongoing advancements within the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…